There are two previously unreported problems with the stem cell lines approved by the Bush administration, the Washington Post reports today. One study finds that all approved lines share a previously unrecognized trait that fosters rejection by the immune systems, “diminishing their potential as medical treatments.” And another study has concluded that at least one-fourth of the approved lines (there are 22 of them) are so difficult to keep alive that they have little potential, even as research tools.
Such news may be too late to affect the presidential election–and no doubt anyone who’s going to vote on the single issue of stem cells has already made up his or her mind one way or the other–but it might add yet more wood on the fire of California’s Proposition 71. In a recent poll, 53% of respondents favored Prop. 71’s passage and only 34% opposed.
Forget dating apps: Here’s how the net’s newest matchmakers help you find love
Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.